Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
Showing page 270 |
first page | previous page | next page | last page |
Overall_Gscore | No. of Cancer Types | ||||
HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
ICAM3 | ENSG00000076662 | 0.00 | 0.00 | 0 | 0 |
ITPR3 | ENSG00000096433 | 0.00 | 0.00 | 0 | 0 |
TRIM33 | ENSG00000197323 | 0.00 | 0.66 | 0 | 4 |
NTSR2 | ENSG00000169006 | 0.00 | 0.00 | 0 | 0 |
CYP2C9 | ENSG00000138109 | 0.00 | 0.00 | 0 | 0 |
CDK10 | ENSG00000185324 | 0.00 | 0.52 | 0 | 4 |
SPARCL1 | ENSG00000152583 | 0.00 | 0.11 | 0 | 1 |
KLHL3 | ENSG00000146021 | 0.00 | 0.00 | 0 | 0 |
CMKLR1 | ENSG00000174600 | 0.00 | 0.00 | 0 | 0 |
CPVL | ENSG00000106066 | 0.00 | 0.00 | 0 | 0 |
IFIT1 | ENSG00000185745 | 0.00 | 0.00 | 0 | 0 |
HSPH1 | ENSG00000120694 | 0.17 | 0.00 | 1 | 0 |
PPARD | ENSG00000112033 | 0.00 | 0.00 | 0 | 0 |
FKTN | ENSG00000106692 | 0.00 | 0.15 | 0 | 1 |
SLC40A1 | ENSG00000138449 | 0.00 | 0.00 | 0 | 0 |
INPP5A | ENSG00000068383 | 0.00 | 0.26 | 0 | 2 |
CDC42BPA | ENSG00000143776 | 0.00 | 0.25 | 0 | 1 |
ST6GAL1 | ENSG00000073849 | 0.00 | 0.00 | 0 | 0 |
TK2 | ENSG00000166548 | 0.15 | 0.14 | 1 | 1 |
PIP4K2B | ENSG00000276293 | 0.00 | 0.15 | 0 | 1 |
Showing page 270 |
first page | previous page | next page | last page |